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Gustafsson et al. [1] have studied by circular dichroism and
Fourier transform infrared spectroscopy the structure and
orientation in a phospholipid environment of the 21 residue
peptide KLLLLKLLLLKLLLLKLLLLK (KL4), a mimic of
surfactant protein B (SP-B) [2]. The lipid environment was
provided by DPPC/PG 7:3 (w/w) in an aqueous dispersion.
One goal of the study was to test the original hypothesis [2]
that in a monolayer of DPPC and PG, namely at an air-water
interface along the alveolar surface in the lung, the KL4 pep-
tide binds to the phospholipid molecules by virtue of hydro-
static interactions of the charged lysine residues with polar
head groups, and by stretches of hydrophobic leucine residues
of the KL4 with phospholipid acyl side chains.
The authors conclude that the KL4 peptide adopts a trans-
membranous orientation in the bilayer through spectroscopic
evidence that indicates that the KL4 peptide lies parallel to the
acyl side chains. They add that ‘this is in sharp contrast to the
mechanism of action ¢rst proposed for SP-B and KL4 [2]’.
They note that the originally proposed interactions between
KL4 and the phospholipid molecules ‘are di⁄cult to envision
with the KL4 helical surface and orientation in a phospholipid
bilayer now found, suggesting another mechanism of action
for KL4 in pulmonary phospholipids’.
A major di⁄culty in the interpretation of data by Gustafs-
son et al. is that they have compared the orientation of the
KL4 peptide in a bilayer with the orientation of the peptide in
a monolayer as originally proposed [2]. As they point out, in a
bilayer, only the centrally situated lysine (Lys-11) would lie in
the total non-polar, hydrocarbon environment, while the ami-
no groups of the remaining lysines (Lys-1, 6, 16 and 21) would
interact with the phospholipid head groups. Such electrostatic
interactions are exactly what was originally proposed for KL4
peptide and SP-B in the environment of phospholipid mole-
cules in a monolayer of pulmonary surfactant [2], with the
exception that Lys-11 along with all the lysine residues, would
also interact with the polar head groups. It is these strong
electrostatic interactions along with the hydrophobic and
van der Waals interactions between hydrophobic stretches of
the protein and acyl side chains of the phospholipids that
provide the lateral strength or ordering of phospholipid mol-
ecules in a monolayer by SP-B or its mimic peptides in pul-
monary surfactant (Fig. 1) [3]. Such ordering is essential for
long-term stability of the surfactant.
Gustafsson et al. also compare the activity of phospholipid
dispersions of KL4 peptide and SP-C over a 60 second period
at 30‡C in a Wilhelmy balance, ¢nding the KL4 peptide dis-
persions somewhat less active. It must be noted that more
than two years were spent in the original studies [2] to deter-
mine the precise constituents, their sources of production and
method of formulation into aqueous dispersions for the opti-
mal production of KL4-surfactant. It is thereby understand-
able that these authors may not have achieved optimal activ-
ity. In addition, KL4-surfactant was originally formulated on
the basis of SP-B, to produce long-term stability of the sur-
factant monolayer, and not necessarily to produce a response
of 60 second duration at 30‡C. Possibly on this basis, a single
instillation of KL4-surfactant generally served to provide per-
manent normal pulmonary function to preterm human infants
in a Phase 2 clinical study [4] and for at least a 24 hour period
in preterm rhesus monkeys [5]. It should be noted that Gus-
tafsson et al. were probably unaware of these latter data since
they were published after the study by Gustafsson et al. was in
press.
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Fig. 1. Two-dimensional theoretical representation of the mechanism
of function of SP-B protein and mimic peptides in the PL mono-
layer. The hydrophilic, charged residues interact with polar head
groups of the PL, whereas the hydrophobic stretches of the peptide
interact with the acyl side chains. These interacting forces induce
stabilization of the PL layer, providing greater capacity to resist sur-
face tension or alveolar collapse. (Reproduced with permission of
Science.)
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